CLINICAL DRUG INVESTIGATION

简称 CLIN DRUG INVEST ·NEW ZEALAND ·出版周期 Monthly ·年均收录 103 篇

2.7

最新影响因子

2.60%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

CLINICAL DRUG INVESTIGATION是一本国际性医学期刊，ISSN号为1173-2563，由Springer International Publishing出版，出版地为瑞士，出版周期为月刊。该期刊的影响因子根据年份有所不同，近年约在2.5左右，属于SCI收录期刊，中科院分区通常位于医学领域的3区或4区。该期刊为非开放获取（非OA）期刊。其发文特点主要集中于临床药物研究领域，包括药物疗效、安全性、药代动力学、药物经济学以及临床试验设计等，旨在为临床医生和研究人员提供药物应用的最新科学证据。杂志的质量较高，审稿流程严格，但需注意其影响因子相对中等，可能在某些领域影响力有限，投稿时需结合自身研究方向和期刊定位进行选择。

影响因子趋势

近期发表

A Randomized Four-Period Cross-Over Phase I Study to Assess Bioavailability, Bioequivalence, and Tolerability of IHL-42X Compared with the Reference Drugs in Healthy Volunteers 2026-09-12

Dose-Dependent Association of Long-Term Metformin Use and Diabetic Nephropathy Risk in Patients with Type 2 Diabetes Mellitus: A Nationwide Population-Based Study in Taiwan 2026-09-12

The Great Transatlantic Divide: The Case of Experimental Neuropharmacology 2026-09-08

Statin Use and Arterial Calcification in the General Population: A Longitudinal Analysis and a Negative Control Population 2026-08-25

Pharmacokinetics and Tolerability of Fexinidazole in Subjects with Hepatic Impairment 2026-08-19

Retrospective Real-World Comparison of Adherence, Persistence, Health-Care Utilization, and Costs Among Biologics for Moderate-to-Severe Psoriasis in China 2026-08-13

Efficacy and Safety of Ustekinumab Biosimilars in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-analysis 2026-08-12

Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait 2026-08-12

Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review 2026-08-08

Signals of Venous Thromboembolism Risk from Drug–Drug Interactions Involving Benzodiazepines and Other Sedative Hypnotics: Self-Controlled Case Series Analyses 2026-07-29